Pfizer’s Competitive Grants Program (various)

Organization
Pfizer
Type
Industry
Comments
Filter list by selecting Oncology for Focus Area
Brief Description

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

The following grants are available:

Pre-clinical & Translational Research in Multiple Myeloma
View RFP (PDF)
Application Due Date: May 17, 2021

NSCLC Therapy Management for Optimal Outcomes
View RFP (PDF)
Application Due Date: May 5, 2021

Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer
View RFP (PDF)
Application Due Date: May 12, 2021

Enzalutamide in the Treatment of Prostate Cancer
View RFP (PDF)
Application Due Date: May 14, 2021